Compare NRC & SCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | SCM |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.2M | 397.8M |
| IPO Year | 1997 | 2012 |
| Metric | NRC | SCM |
|---|---|---|
| Price | $14.97 | $9.42 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 113.3K | ★ 269.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | 4.39% | ★ 14.03% |
| EPS Growth | ★ 4707.69 | 123.75 |
| EPS | ★ 50.00 | 0.78 |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.29 | $12.42 |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $9.76 | $9.29 |
| 52 Week High | $22.79 | $15.39 |
| Indicator | NRC | SCM |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 19.86 |
| Support Level | $14.78 | $9.29 |
| Resistance Level | $16.63 | $12.40 |
| Average True Range (ATR) | 0.90 | 0.35 |
| MACD | 0.43 | -0.05 |
| Stochastic Oscillator | 81.73 | 9.62 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.